COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,036 Articles (21,527 medRxiv, 7,509 bioRxiv)

Most recent first Previous |  Page 1666: Articles 16651-16660  | Next

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Wang, Z., Schmidt, F., Weisblum, Y., Muecksch, F., Barnes, C. O., Finkin, S., Schaefer-Babajew, D., Cipolla, M., Gaebler, C., Lieberman, J. A., Yang, Z., Abernathy, M. E., Huey-Tubman, K. E., Hurley, A., Turroja, M., West, K. A., Gordon, K., Millard, K. G., Ramos, V., Silva, J. D., Xu, J., Colbert, R. A., Patel, R., Dizon, J. P., Unson-O'Brien, C., Shimeliovich, I., Gazumyan, A., Caskey, M., Bjorkman, P. J., Casellas, R., Hatziioannou, T., Bieniasz, P. D., Nussenzweig, M. C.
10.1101/2021.01.15.426911 — Posted: 2021-01-19 Discussion: Onsite
Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera
Muik, A., Wallisch, A.-K., Saenger, B., Swanson, K. A., Muehl, J., Chen, W., Cai, H., Sarkar, R., Tuereci, O., Dormitzer, P. R., Sahin, U.
10.1101/2021.01.18.426984 — Posted: 2021-01-19 Discussion: Onsite | Offsite
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Wibmer, C. K., Ayres, F., Hermanus, T., Madzivhandila, M., Kgagudi, P., Lambson, B. E., Vermeulen, M., van den Berg, K., Rossouw, T., Boswell, M., Ueckermann, V., Meiring, S., von Gottberg, A., Cohen, C., Morris, L., Bhiman, J. N., Moore, P. L.
10.1101/2021.01.18.427166 — Posted: 2021-01-19 Discussion: Onsite
A national analysis of trends in COVID-19 infection and clinical management in Veterans Health Administration medical facilities
Aboumrad, M., Shiner, B., Riblet, N., Huizenga, H., Neupane, N., Young-Xu, Y.
10.1101/2021.01.18.427092 — Posted: 2021-01-18
Large scale genomic and evolutionary study reveals SARS-CoV-2 virus isolates from Bangladesh strongly correlate with European origin and not with China.
Rabbi, M. F. A., Khan, M. I., Hasan, S., Chalita, M., Hasan, K. N., Sufian, A., Hosen, M. B., Polol, M. N. I., Naima, J., Lee, K., Kim, Y. O., Razu, M. H., Khan, M., Rahman, M. M., Chun, J., Khaleque, M. A., Hasan, N. A., Colwell, R. R., Akhteruzzaman, S.
10.1101/2021.01.17.425424 — Posted: 2021-01-18
From COVID-19 to the Common Cold: Novel Host-Targeted, Pan-Respiratory Antiviral Small Molecule Therapeutics
Selvarajah, S., Lingappa, A. F., Michon, M., Yu, S. F., Macieik, A., Mallesh, S., Appiah, U., Crabtree, J., Copeland, K., Lin, J., Akintunde, O., Nichols, C., Petrouski, E., Moreira, A. R., Jiang, I.-t., DeYarman, N., Broce, S., Brown, I., Lau, S., Segal, I., Goldsmith, D., Hong, S., Asundi, V., Briggs, E. M., Phyo, N. S., Froehlich, M., Hogan, R. J., Tripp, R. A., Anand, S., Campi, T. W., Ford, M., Reed, J. C., Onisko, B., Matlack, K., Dey, D., Lingappa, J. R., Prasad, M. D., Kitaygorodskyy, A., Solas, D., Paulvannan, K., Lingappa, V. R.
10.1101/2021.01.17.426875 — Posted: 2021-01-18
Tropism of SARS-CoV-2 for Developing Human Cortical Astrocytes
Andrews, M. G., Mukhtar, T., Eze, U. C., Simoneau, C. R., Perez, Y., Mostajo-Radji, M. A., Wang, S., Velmeshev, D., Salma, J., Kumar, G. R., Pollen, A. A., Crouch, E. E., Ott, M., Kriegstein, A. R.
10.1101/2021.01.17.427024 — Posted: 2021-01-18
SARS-CoV-2 infection reduces Krüppel-Like Factor 2 in human lung autopsy
Lee, T.-H., Wu, D., Guzy, R., Schoettler, N., Adegunsoye, A., Mueller, J., Hussein, A., Sperling, A., Mutlu, G. M., Fang, Y.
10.1101/2021.01.15.426691 — Posted: 2021-01-18
SARS-CoV-2 RECoVERY: a multi-platform open-source bioinformatic pipeline for the automatic construction and analysis of SARS-CoV-2 genomes from NGS sequencing data
De Sabato, L., Vaccari, G., Knijn, A., Ianiro, G., Di Bartolo, I., Morabito, S.
10.1101/2021.01.16.425365 — Posted: 2021-01-18
Fluorescent Glycan Fingerprinting of SARS2 Spike Proteins
Wu, Z. L., Ertelt, J. M.
10.1101/2021.01.16.426965 — Posted: 2021-01-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).